MDA-MB-231 cells model the triple-negative breast cancer subtype, which is characterized by the absence of estrogen- (ER-), progesterone- (PR-), and Her2- (Her2-) receptors. This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.